FDA Import Refusal AEK-9070749-6/20003/1 — BOEHRINGER INGELHEIM INDIA PVT
The FDA refused shipment AEK-9070749-6/20003/1 from BOEHRINGER INGELHEIM INDIA PVT (India) on Jan 2, 2026. The refused product falls under Drugs and Biologics — LINAGLIPTIN (ANTI-DIABETIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Jan 2, 2026
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 61PDA66 LINAGLIPTIN (ANTI-DIABETIC)
- Charges
- 75